WallStSmart

Advanced Micro Devices Inc (AMD)vsWellchange Holdings Company Limited (WCT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Advanced Micro Devices Inc generates 1416223% more annual revenue ($34.64B vs $2.45M). AMD leads profitability with a 12.5% profit margin vs -154.5%. AMD earns a higher WallStSmart Score of 63/100 (C+).

AMD

Buy

63

out of 100

Grade: C+

Growth: 9.3Profit: 6.0Value: 4.3Quality: 9.0
Piotroski: 6/9Altman Z: 3.74

WCT

Avoid

27

out of 100

Grade: F

Growth: 6.0Profit: 2.0Value: 5.0Quality: 6.5
Piotroski: 3/9Altman Z: 2.03

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMD6 strengths · Avg: 9.7/10
Market CapQuality
$577.96B10/10

Mega-cap, among the largest globally

Revenue GrowthGrowth
34.1%10/10

Revenue surging 34.1% year-over-year

EPS GrowthGrowth
217.1%10/10

Earnings expanding 217.1% YoY

Debt/EquityHealth
0.0710/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.7410/10

Safe zone — low bankruptcy risk

Free Cash FlowQuality
$2.38B8/10

Generating 2.4B in free cash flow

WCT2 strengths · Avg: 9.5/10
Price/BookValuation
0.2x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.129/10

Conservative balance sheet, low leverage

Areas to Watch

AMD3 concerns · Avg: 3.0/10
Price/BookValuation
9.2x4/10

Trading at 9.2x book value

Return on EquityProfitability
7.1%3/10

ROE of 7.1% — below average capital efficiency

P/E RatioValuation
135.3x2/10

Premium valuation, high expectations priced in

WCT4 concerns · Avg: 2.5/10
Market CapQuality
$5.83M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-51.3%2/10

ROE of -51.3% — below average capital efficiency

EPS GrowthGrowth
-3.1%2/10

Earnings declined 3.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : AMD

The strongest argument for AMD centers on Market Cap, Revenue Growth, EPS Growth. Revenue growth of 34.1% demonstrates continued momentum. PEG of 1.05 suggests the stock is reasonably priced for its growth.

Bull Case : WCT

The strongest argument for WCT centers on Price/Book, Debt/Equity. Revenue growth of 12.9% demonstrates continued momentum.

Bear Case : AMD

The primary concerns for AMD are Price/Book, Return on Equity, P/E Ratio. A P/E of 135.3x leaves little room for execution misses.

Bear Case : WCT

The primary concerns for WCT are Market Cap, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

AMD profiles as a growth stock while WCT is a turnaround play — different risk/reward profiles.

AMD is growing revenue faster at 34.1% — sustainability is the question.

AMD generates stronger free cash flow (2.4B), providing more financial flexibility.

Monitor SEMICONDUCTORS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AMD scores higher overall (63/100 vs 27/100) and 34.1% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Advanced Micro Devices Inc

TECHNOLOGY · SEMICONDUCTORS · USA

Advanced Micro Devices, Inc. (AMD) is an American multinational semiconductor company based in Santa Clara, California, that develops computer processors and related technologies for business and consumer markets. AMD's main products include microprocessors, motherboard chipsets, embedded processors and graphics processors for servers, workstations, personal computers and embedded system applications.

Visit Website →

Wellchange Holdings Company Limited

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Wellchange Holdings Company Limited (WCT) operates at the forefront of the healthcare and wellness industry, delivering innovative solutions aimed at improving consumer health and overall lifestyle. By leveraging advanced technology and adhering to sustainable practices, WCT offers a comprehensive portfolio of products and services that prioritize well-being. The company's robust focus on research and development, coupled with strategic partnerships, uniquely positions it to capitalize on the increasing global demand for health-focused solutions. As a result, WCT presents a compelling investment opportunity for institutional investors seeking to gain exposure to a rapidly expanding market.

Visit Website →

Want to dig deeper into these stocks?